Target intelligence / Profile preview

Phosphatidylinositol 3-kinase catalytic subunit gamma (PI3Kγ (gene symbol: PIK3CG; catalytic subunit also referred to as p110γ))

Target
PI3Kγ (gene symbol: PIK3CG; catalytic subunit also referred to as p110γ)
Molecular classification
Enzyme (lipid kinase; phosphoinositide 3-kinase), Signal transduction enzyme in the PI3K/AKT pathway, Class I PI3K, subclass IB isoform, Scaffolding protein (AKAP-like functions reported for PI3Kγ complexes)
01

Overview

Phosphatidylinositol 3-kinase catalytic subunit gamma (p110γ; gene PIK3CG) is the catalytic component of the class IB PI3K that partners with regulatory subunits p101 or p87/p84 to form PI3Kγ complexes activated primarily downstream of GPCRs via direct Gβγ binding and also by Ras, leading to production of PtdIns(3,4,5)P3 and activation of PI3K/AKT signaling pathways controlling chemotaxis, inflammation, cardiac β-adrenergic signaling, cell survival, and proliferation; dysregulation contributes to inflammatory disease, cardiovascular dysfunction, and cancer, and the catalytic site is druggable with small-molecule inhibitors as shown in human PI3Kγ crystal structures.

Other names
Phosphoinositide 3-kinase gammaPI3K gammap110 gamma (p110γ)PIK3CG (gene)Class IB PI3K catalytic subunit
02

Mechanism of action

Competitive inhibition of the ATP-binding site in the p110γ kinase domain, blocking phosphorylation of PtdIns(4,5)P2 to PtdIns(3,4,5)P3. Functional antagonism of GPCR→Gβγ→PI3Kγ signaling, reducing downstream AKT/PDK1 recruitment and signaling outputs. Modulation of Ras-augmented activation where inhibitors prevent Ras-enhanced PI3Kγ activity.

03

Biological functions

Signal transduction downstream of G protein-coupled receptors via Gβγ activationProduction of PtdIns(3,4,5)P3 to recruit PH-domain effectors (e.g., AKT, PDK1)Ras-dependent activation integrating inputs from RTKs and Toll/IL-1 receptorsRegulation of chemotaxis, immune cell migration, and inflammatory responsesRoles in cardiac function and β-adrenergic receptor signaling; scaffolding with PKA/PDE3/PDE4Cell proliferation, survival, and cytoskeletal rearrangement via PI3K/AKT signaling
04

Disease associations

Cancer (tumor progression and PI3K pathway dysregulation)Inflammation and immune-mediated diseasesCardiovascular disease (cardiac function and β-adrenergic signaling modulation)Infection/host defense (GPCR-driven leukocyte responses)
05

Safety considerations

Immunomodulation/immunosuppression risk due to central role in leukocyte signalingCardiovascular signaling perturbation given roles in cardiac β-adrenergic pathways and scaffolding functionsOn-target metabolic and proliferative pathway effects via PI3K/AKT signaling
06

Interacting drugs

PI3Kγ-selective and pan-PI3K inhibitors that bind the p110γ catalytic site; structural studies show small-molecule complexes with PI3Kγ

1 more in the full profile.

07

Biomarkers

PIK3CG expression/activity in myeloid/immune cells as a pharmacodynamic indicator for PI3Kγ-targeted agents (inference grounded in immune-centric role)Levels of PtdIns(3,4,5)P3 or downstream p-AKT (Thr308/Ser473) as pathway readouts for PI3K activityGPCR-driven chemotaxis assays in leukocytes as functional biomarkers of PI3Kγ inhibition (inference from role in chemotaxis)

Beyond the preview

Go deeper on Phosphatidylinositol 3-kinase catalytic subunit gamma (PI3Kγ (gene symbol: PIK3CG; catalytic subunit also referred to as p110γ)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol 3-kinase catalytic subunit gamma (PI3Kγ (gene symbol: PIK3CG; catalytic subunit also referred to as p110γ)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call